MAM
Brand Fevicol benefited most from Dabangg 2 association, Ormax
MUMBAI: Fevicol leads the list of brand that tied up with Salman Khan‘s Dabangg 2, according to an independent study conducted by research agency Ormax Media.
Fevicol evidently benefited from the usage of the brand name in the popular song ‘Fevicol Se‘, featuring Kareena Kapoor with Salman Khan.
The study was conducted a week after the release of the film. As many as 12 brands had associated with Dabangg 2.
Following Fevicol on the list is Colgate Active Salt, which had run a contest called the ‘Colgate Active Salt Dabangg 2 Challenge‘ with Sonakshi Sinha.
Third on the list is Suzuki Hayate that is being endorsed by Khan himself. It had also run a multimedia contest with bikes as prizes.
The study noted that other brands like Thums Up, Gillette, Dixcy Scott and Fastrack could not milk the association because of which they did not register significant recall.
Meanwhile, despite having no association with the movie, Revital emerged as the brand with the strongest association with Khan. The consistent brand endorsement by Khan over the last few months ensured that it benefits from any ‘Salman Khan‘ event, including a film release like Dabangg 2.
Ormax Media CEO Shailesh Kapoor said, “Upto 15-20 brands tie up with big films, but only about 3-4 actually derive any real value out of the association. We had conducted a similar study when Ra.One released, and now plan to conduct such researches for big releases at regular intervals. Using such research, brands can benefit from learnings derived from associations of various kinds, and use these learnings as an input into their own film associations.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
